A 10 day pilot study of TTP 399 in patients with type 2 diabetes mellitus
Phase of Trial: Phase II
Latest Information Update: 22 Jun 2016
At a glance
- Drugs TTP 399 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 22 Jun 2016 New trial record
- 14 Jun 2016 Results were presented at the American Diabetes Association 76th Scientific Sessions 2016, according to a vTv Therapeutics LLC media release.
- 14 Jun 2016 Results published in a vTv Therapeutics LLC media release.